Nantahala Capital Management, LLC - 03 Nov 2025 SCHEDULE 13D/A Report for Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
Evoke Pharma Inc Common Stock, par value $0.0001 per share
Symbol
EVOK
Shares outstanding
1,678,743 shares
Disclosed Ownership
268,431 shares
Ownership
16%
Form type
SCHEDULE 13D/A
Filing time
04 Nov 2025, 11:40:13 UTC
Date of event
03 Nov 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 16% 268,431 0 268,431 /s/ Taki Vasilakis Taki Vasilakis, Chief Compliance Officer 0001472322
Harkey Wilmot B. 16% 268,431 0 268,431 /s/ Wilmot B. Harkey Wilmot B. Harkey 0001775952
Mack Daniel 16% 268,431 0 268,431 /s/ Daniel Mack Daniel Mack 0001775831